Patients should alternate which hand performs the injection when self-administering, and those with visual or mobility concerns can ask a family member or healthcare provider to assist
[9] If your UHC plan excludes weight loss drugs but you have heart disease risk factors, ask your doctor about prescribing Wegovy for CV risk reduction insteadthis may open a different coverage pathway
Temporary soreness, redness, or bruising at the injection site Mild itching or swelling at the site Occasional nausea, headache, or lightheadedness shortly after injection Allergic reaction (uncommon) Infection at the injection site if sterile technique is compromised Nutrient imbalance with prolonged, unsupervised use particularly relevant for patients with kidney disease The FDA has warned against unapproved injectable products marketed for fat reduction, citing risks including infection, scarring, and skin deformities
Over the same period, public interest in these drugs exploded as well, with Google searches for "GLP-1" increasing twentyfold
Product Selection Tips Confirm CAS numbers and purity (99% HPLC)